Skip to main content

Contraception clinical trials at UCSF

4 in progress, 1 open to eligible people

Contraception means preventing pregnancy. UCSF is looking for young women aged 18-25 to join a study on training for clinic staff and contraceptive education. This study is called "UCSF College Health Study on Contraceptive Training and Education at Community Colleges." There are also three other contraception studies happening at UCSF right now, but they are not accepting new participants.

Showing trials for
  • UCSF College Health Study on Contraceptive Training and Education at Community Colleges

    open to eligible females ages 18-25

    The purpose of this study is to measure whether a training and education intervention for clinic staff and young women aged 18-25 on contraceptive methods, including intrauterine devices (IUDs) and the implant, will result in greater contraceptive knowledge and access among students in community colleges.

    San Francisco, California

  • Study of the Safety and Efficacy of Ulipristal Acetate (UPA) Used Daily as a Contraceptive

    Sorry, currently not accepting new patients, but might later

    This is a Phase IIb multicenter, open-label, non-comparative trial of continuous daily oral 10 mg of ulipristal acetate (UPA) to evaluate its contraceptive efficacy as the primary method of contraception.

    San Francisco, California and other locations

  • "My Decision" Tubal Sterilization Decision Support Tool

    Sorry, in progress, not accepting new patients

    This study seeks to test a web-based decision support tool developed to enhance low-income women's ability to make informed decisions about tubal sterilization that align with their preferences, values and reproductive goals. Half of participants will receive usual care, while the other half will use the web-based decision aid plus usual care. The investigators hypothesize that compared to women who receive usual care alone, women randomized to the decision aid arm will have greater knowledge about sterilization and alternative options, lower decisional conflict, and will be more satisfied with their contraceptive decision at 3-month follow-up.

    San Francisco, California and other locations

  • Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard

    Sorry, in progress, not accepting new patients

    This will be a multi-site, participant-blinded, randomized clinical trial. The investigators will randomize 1000 eligible participants in a 4:1 ratio to two different copper IUDs: 800 to Mona Lisa NT Cu380 Mini and 200 to ParaGard.

    San Francisco, California and other locations

Our lead scientists for Contraception research studies include .

Last updated: